116
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Clinical Features and Outcomes Associated with Bronchial Asthma Among COVID-19 Hospitalized Patients

, ORCID Icon, ORCID Icon, , , & show all
Pages 775-781 | Published online: 08 Jun 2022

References

  • Zhang J, Dong X, Cao Y, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:10.1111/all.14238
  • Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.006
  • Wang Y, Ao G, Qi X, Xie B. The association between COVID‐19 and asthma: a systematic review and meta‐analysis. Clin Exp Allergy. 2020;50(11):1274–1277. doi:10.1111/cea.13733
  • Mendes NF, Jara CP, Mansour E, Araújo EP, Velloso LA. Asthma and COVID-19: a systematic review. Allergy, Asthma Clin Immunol. 2021;17(1). doi:10.1186/s13223-020-00509-y
  • Eggert LE, He Z, Collins W, et al. Asthma phenotypes, associated comorbidities, and long‐term symptoms in COVID‐19. Allergy. 2021;19(1):173–185.
  • Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052. doi:10.1001/jama.2020.6775
  • Rosenthal JA, Awan SF, Fintzi J, Keswani A, Ein D. Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019. Ann Allergy, Asthma Immunol. 2021;126(1):93–95. doi:10.1016/j.anai.2020.10.002
  • Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo CA, Liang L. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020;146(2):327–329.e4. doi:10.1016/j.jaci.2020.06.001
  • Kimura H, Francisco D, Conway M, et al. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J Allergy Clin Immunol. 2020;146(1):80–88.e8. doi:10.1016/j.jaci.2020.05.004
  • Peters MC, Sajuthi S, Deford P, et al. COVID-19 related genes in sputum cells in asthma: relationship to demographic features and corticosteroids. Am J Respir Crit Care Med. 2020;202(1):83–90. doi:10.1164/rccm.202003-0821OC
  • Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203–206.e3. doi:10.1016/j.jaci.2020.04.009
  • Prieto-Alhambra D, Balló E, Coma E, et al. Hospitalization and 30-day fatality in 121,263 COVID-19 outpatient cases. MedRxiv. 2020;20090050. doi:10.1101/2020.05.04.20090050
  • Borobia A, Carcas A, Arnalich F, et al. A cohort of patients with COVID-19 in a major teaching hospital in Europe. J Clin Med. 2020;9(6):1733. doi:10.3390/jcm9061733
  • Liu S, Cao Y, Du T, Zhi Y. Prevalence of comorbid asthma and related outcomes in COVID-19: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2021;9(2):693–701. doi:10.1016/j.jaip.2020.11.054
  • Pallasaho P, Ronmark E, Haahtela T, Sovijarvi ARA, Lundback B. Degree and clinical relevance of sensitization to common allergens among adults: a population study in Helsinki, Finland. Clin Exp Allergy. 2006;36(4):503–509. doi:10.1111/j.1365-2222.2006.02460.x
  • Warm K, Backman H, Lindberg A, Lundbäck B, Rönmark E. Low incidence and high remission of allergic sensitization among adults. J Allergy Clin Immunol. 2012;129(1):136–142. doi:10.1016/j.jaci.2011.08.033
  • Li C, Ye J, Chen Q, et al. Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging. 2020;12(15):15670–15681. doi:10.18632/aging.103770
  • Peltzer B, Manocha KK, Ying X, et al. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID‐19. J Cardiovasc Electrophysiol. 2020;31(12):3077–3085. doi:10.1111/jce.14770
  • Budweiser S, Ş B, Jörres RA, et al. Patients’ treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections. Respir Res. 2021;22(1). doi:10.1186/s12931-021-01756-2
  • Caminati M, Vultaggio A, Matucci A, et al. Asthma in a large COVID-19 cohort: prevalence, features, and determinants of COVID-19 disease severity. Respir Med. 2021;176:106261. doi:10.1016/j.rmed.2020.106261
  • Ferastraoaru D, Hudes G, Jerschow E, et al.Eosinophilia in asthma patients is protective against severe COVID-19 illness. J Allergy Clin Immunol Pract. 2021;(3):1152–1162.e3. doi:10.1016/j.jaip.2020.12.045
  • Valverde-Monge M, Cañas JA, Barroso B, et al. Eosinophils and chronic respiratory diseases in hospitalized COVID-19 patients. Front Immunol. 2021;12:668074. doi:10.3389/fimmu.2021.668074
  • Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 2020;55(5):2001009. doi:10.1183/13993003.01009-2020
  • Yamaya M, Nishimura H, Deng X, et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020;58(3):155–168. doi:10.1016/j.resinv.2019.12.005
  • Matsuyama S, Kawase M, Nao N, et al. The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells. J Virol. 2020;95(1). doi:10.1128/JVI.01648-20
  • Jeon S, Ko M, Lee J, et al. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrob Agents Chemother. 2020;64(7):e00819–20. doi:10.1128/AAC.00819-20
  • Chen D, Zhang S, Feng Y, et al. Decreased eosinophil counts and elevated lactate dehydrogenase predict severe COVID-19 in patients with underlying chronic airway diseases. Postgrad Med J;2021. postgradmedj-2021-139704. doi:10.1136/postgradmedj-2021-139704